Marcus Smith Noel

1.6k total citations
68 papers, 803 citations indexed

About

Marcus Smith Noel is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marcus Smith Noel has authored 68 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 17 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marcus Smith Noel's work include Pancreatic and Hepatic Oncology Research (28 papers), Cancer Genomics and Diagnostics (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Marcus Smith Noel is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Cancer Genomics and Diagnostics (13 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Marcus Smith Noel collaborates with scholars based in United States, Netherlands and Taiwan. Marcus Smith Noel's co-authors include Kevin Fiscella, Aram F. Hezel, Marion L. Hartley, David C. Linehan, Maeve A. Lowery, Donghua Yin, Carrie Turich Taylor, Carolyn D. Britten, Brian A. Belt and David P. Ryan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Marcus Smith Noel

59 papers receiving 795 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus Smith Noel United States 13 521 228 160 143 135 68 803
Leïla Bengrine-Lefèvre France 15 573 1.1× 190 0.8× 103 0.6× 73 0.5× 151 1.1× 45 806
Alexandros Xyrafas Switzerland 16 766 1.5× 209 0.9× 185 1.2× 267 1.9× 314 2.3× 38 1.1k
Philippe Rochigneux France 14 406 0.8× 157 0.7× 97 0.6× 79 0.6× 132 1.0× 39 649
Concetta Elisa Onesti Italy 16 465 0.9× 109 0.5× 334 2.1× 255 1.8× 287 2.1× 58 937
Hideki Ueno Japan 14 389 0.7× 97 0.4× 192 1.2× 168 1.2× 140 1.0× 44 706
Oyewale O. Abidoye United States 13 451 0.9× 103 0.5× 143 0.9× 77 0.5× 221 1.6× 24 657
Alice Zervoudakis United States 11 690 1.3× 56 0.2× 118 0.7× 320 2.2× 133 1.0× 34 851
Meredith K. Chuk United States 14 429 0.8× 133 0.6× 175 1.1× 116 0.8× 260 1.9× 29 858
Aránzazu Manzano Spain 16 571 1.1× 95 0.4× 240 1.5× 200 1.4× 308 2.3× 58 1.1k

Countries citing papers authored by Marcus Smith Noel

Since Specialization
Citations

This map shows the geographic impact of Marcus Smith Noel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Smith Noel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Smith Noel more than expected).

Fields of papers citing papers by Marcus Smith Noel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Smith Noel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Smith Noel. The network helps show where Marcus Smith Noel may publish in the future.

Co-authorship network of co-authors of Marcus Smith Noel

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus Smith Noel. A scholar is included among the top collaborators of Marcus Smith Noel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus Smith Noel. Marcus Smith Noel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Dung T., Anna M. Varghese, Marcus Smith Noel, et al.. (2026). Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer. Journal for ImmunoTherapy of Cancer. 14(1). e011284–e011284.
2.
Li, Peter, Xue Geng, Hongkun Wang, et al.. (2025). Real-world microscopic residual disease (MRD) monitoring with circulating tumor DNA (ctDNA) in pancreatic adenocarcinoma (PDAC).. Journal of Clinical Oncology. 43(4_suppl). 696–696.
3.
Noel, Marcus Smith, Bhaskar Srivastava, Scott R. Daigle, et al.. (2024). Phase 1/2 trial of the HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab: Clinical update.. Journal of Clinical Oncology. 42(16_suppl). 3083–3083. 6 indexed citations
4.
Weinberg, Benjamin A., Allison A. Fitzgerald, Zoe X. Malchiodi, et al.. (2024). Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.. Journal of Clinical Oncology. 42(17_suppl). LBA4132–LBA4132. 2 indexed citations
5.
6.
Noel, Marcus Smith, et al.. (2024). Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal cancers with microscopic residual disease.. Journal of Clinical Oncology. 42(3_suppl). TPS765–TPS765. 1 indexed citations
7.
Libbey, N. Peter, Benjamin A. Weinberg, Marcus Smith Noel, et al.. (2024). Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer. Journal of Gastrointestinal Cancer. 55(2). 852–861.
8.
Xiao, Jerry, Marc E. Lippman, Paula R. Pohlmann, et al.. (2023). Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis. Cancers. 15(6). 1831–1831. 6 indexed citations
9.
Badri, Nabeel, Jason Zittel, Andrea Baran, et al.. (2023). Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial.. Journal of Clinical Oncology. 41(16_suppl). 12047–12047. 1 indexed citations
10.
Xiao, Jerry, Xue Geng, Hongkun Wang, et al.. (2023). Success rates and clinicopathologic associations with experimental outcomes of a novel circulating tumor cell (CTC) technology in advanced colon cancer (CC) and pancreatic cancer (PC).. Journal of Clinical Oncology. 41(4_suppl). 805–805. 1 indexed citations
11.
Weinberg, Benjamin A., Martin Gutierrez, Anteneh Tesfaye, et al.. (2023). Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC).. Journal of Clinical Oncology. 41(16_suppl). TPS4194–TPS4194. 1 indexed citations
12.
13.
Noel, Marcus Smith, Semmie Kim, Marion L. Hartley, et al.. (2022). A randomized phase II study of SM‐88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond. Cancer Medicine. 11(22). 4169–4181. 6 indexed citations
14.
Hartley, Marion L., et al.. (2022). The Role of Immunotherapy in Pancreatic Cancer. Current Oncology. 29(10). 6864–6892. 60 indexed citations
15.
Noel, Marcus Smith, et al.. (2022). Gastric carcinoma's primary presentation as multiple cutaneous nodules throughout the body. Cancer Treatment and Research Communications. 31. 100532–100532. 3 indexed citations
16.
Johnson, Douglas B., Fengmin Zhao, Marcus Smith Noel, et al.. (2020). Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131). Clinical Cancer Research. 26(8). 1812–1819. 42 indexed citations
17.
Noel, Marcus Smith & Kevin Fiscella. (2019). Disparities in Pancreatic Cancer Treatment and Outcomes. Health Equity. 3(1). 532–540. 95 indexed citations
18.
19.
Mohamed, Mostafa, Haoming Qiu, Marcus Smith Noel, et al.. (2015). Comparison of Outcomes Between SBRT, Yittrium-90 Radioembolization, Transarterial Chemoembolization, and Radiofrequency Ablation as Bridge to Transplant for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 93(3). E124–E124. 3 indexed citations
20.
Noel, Marcus Smith, Jonathan W. Friedberg, & Paul M. Barr. (2012). Novel agents in mantle cell lymphoma. Best Practice & Research Clinical Haematology. 25(2). 191–200. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leïla Bengrine-Lefèvre Breakdown of academic impact, for papers by Alexandros Xyrafas Breakdown of academic impact, for papers by Philippe Rochigneux Breakdown of academic impact, for papers by Concetta Elisa Onesti Breakdown of academic impact, for papers by Hideki Ueno Breakdown of academic impact, for papers by Oyewale O. Abidoye Breakdown of academic impact, for papers by Alice Zervoudakis Breakdown of academic impact, for papers by Meredith K. Chuk Breakdown of academic impact, for papers by Aránzazu Manzano
Rankless by CCL
2026